Elsevier

Annals of Oncology

Volume 31, Issue 9, September 2020, Pages 1273-1275
Annals of Oncology

Letter to the Editor
Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis

https://doi.org/10.1016/j.annonc.2020.05.005Get rights and content
Under an Elsevier user license
open archive

Cited by (0)